* Prophase Labs Inc PRPH.OQ PRPH.O is expected to show a
rise
in quarterly revenue when it reports results on March 30.
* The New York City-based company is expected to report a
454.2% increase in revenue to $28.612 million from $5.16 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prophase Labs Inc
is for
earnings of 44 cents per share. For the same quarter last year,
the company reported a loss of 23 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prophase
Labs Inc
is $12, above its last closing price of $7.37.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 0.07 0.07 -0.26 Missed -471.4
Jun. 30 2021 0.34 -0.05 Missed -114.9
Mar. 31 2021 0.20 0.21 0.27 Beat 31.7
Dec. 31 2020 -0.02 -0.02 -0.23 Missed -1,050
This summary was machine generated March 28 at 13:06 GMT. All
figures in US dollars unless otherwise stated